R1	Has_qualifier Arg1:T2 Arg2:T3	
R2	Has_qualifier Arg1:T6 Arg2:T7	
*	OR T4 T5
R3	AND Arg1:T6 Arg2:T4	
*	OR T11 T14 T13
*	OR T10 T12
R4	AND Arg1:T9 Arg2:T10	
R5	Has_qualifier Arg1:T20 Arg2:T19	
R6	multi Arg1:T18 Arg2:T21	
*	OR T18 T20
R7	Has_value Arg1:T23 Arg2:T25	
R8	Has_value Arg1:T24 Arg2:T25	
*	OR T23 T24
*	OR T26 T27 T28
R9	Has_value Arg1:T26 Arg2:T29	
*	OR T31 T32
R10	Has_value Arg1:T31 Arg2:T33	
*	OR T26 T31
R11	Subsumes Arg1:T23 Arg2:T26	
R12	Has_qualifier Arg1:T39 Arg2:T38	
R13	Has_temporal Arg1:T41 Arg2:T40	
R14	Has_temporal Arg1:T41 Arg2:T42	
R15	Has_temporal Arg1:T43 Arg2:T44	
R16	AND Arg1:T41 Arg2:T46	
T1	Non-representable 0 46	Therapy area located outside of head and neck;
T2	Condition 54 67	skin diseases
T3	Qualifier 79 117	interfere with the efficacy evaluation
T4	Drug 157 164	isotope
T5	Drug 168 171	PDT
T6	Procedure 181 190	treatment
T7	Qualifier 197 241	might interfere with the efficacy evaluation
T9	Condition 244 251	Allergy
T10	Drug 255 265	porphyrins
T11	Condition 281 297	Photosensitivity
T12	Drug 270 279	analogues
T13	Condition 299 308	Porphyria
T14	Condition 310 331	Allergic constitution
T16	Condition 334 348	Scar diathesis
T17	Condition 351 379	Immunocompromised conditions
T18	Condition 382 416	Electrocardiographic abnormalities
T19	Qualifier 420 427	organic
T20	Condition 428 442	heart diseases
T21	Procedure 382 402	Electrocardiographic
T22	Condition 445 466	Coagulation disorders
T23	Measurement 469 476;486 495	Hepatic functions
T24	Measurement 480 495	renal functions
T25	Value 496 504	abnormal
T26	Measurement 506 530	alanine aminotransferase
T27	Measurement 534 556	aspartate transaminase
T28	Measurement 560 575	total bilirubin
T29	Value 576 609	> 1.5 upper limit of normal [ULN]
T31	Measurement 614 630	serum creatinine
T32	Measurement 634 653	blood urea nitrogen
T33	Value 654 663	> 1.5 ULN
T37	Condition 667 687	Psychiatric diseases
T38	Qualifier 689 695	Severe
T39	Condition 696 712	endocrinopathies
T40	Temporal 715 723	Previous
T41	Procedure 724 731	therapy
T42	Temporal 739 762	within the last 4 weeks
T43	Observation 765 802	Participation in any clinical studies
T44	Temporal 803 826	within the last 4 weeks
T45	Non-query-able 829 897	Be judged not suitable to participate the study by the investigators
T46	Condition 735 738	PWS
